Cold Sore Fever Blister Treatment is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Target Corporation. The primary component is Docosanol.
Product ID | 11673-926_56c56e3a-de3b-4c28-9b3e-a17b02b7b2a1 |
NDC | 11673-926 |
Product Type | Human Otc Drug |
Proprietary Name | Cold Sore Fever Blister Treatment |
Generic Name | Docosanol |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2020-07-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA208754 |
Labeler Name | TARGET Corporation |
Substance Name | DOCOSANOL |
Active Ingredient Strength | 100 mg/g |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2020-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0363-9220 | Cold Sore Fever Blister Treatment | Docosanol |
0363-9222 | Cold Sore Fever Blister Treatment | Docosanol |
11673-846 | Cold Sore Fever Blister Treatment | Docosanol |
11673-926 | Cold Sore Fever Blister Treatment | Docosanol |
11822-0951 | Cold Sore Fever Blister Treatment | Docosanol |
11822-3927 | Cold Sore Fever Blister Treatment | Docosanol |
11822-3951 | Cold Sore Fever Blister Treatment | Docosanol |
11822-3977 | Cold Sore Fever Blister Treatment | Docosanol |
11822-4763 | Cold Sore Fever Blister Treatment | Docosanol |
21130-823 | Cold Sore Fever Blister Treatment | Docosanol |
30142-981 | Cold Sore Fever Blister Treatment | Docosanol |
0135-0200 | ABREVA | docosanol |
0135-0300 | ABREVA | docosanol |
30142-322 | Cold Sore Fever Blister | Docosanol |
0363-2981 | Docosanol | Docosanol |
0472-2981 | Docosanol | Docosanol |
0591-2981 | Docosanol | Docosanol |
21130-422 | Docosanol | Docosanol |
21922-023 | Docosanol | Docosanol |